000			01902 a2200553 4500
005			20250517125111.0
264		0	_c20170626
008			201706s 0 0 eng d
022			_a0946-1965
024	7		_a10.5414/CP202772 _2doi
040			_aNLM _beng _cNLM
100	1		_aRathmann, Wolfgang
245	0	0	_aTreatment persistence in the use of basal insulins in Poland and Germany . _h[electronic resource]
260			_bInternational journal of clinical pharmacology and therapeutics _cFeb 2017
300			_a119-125 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Multicenter Study
650	0	4	_aAged
650	0	4	_aBiomarkers _xblood
650	0	4	_aBlood Glucose _xdrug effects
650	0	4	_aChi-Square Distribution
650	0	4	_aComorbidity
650	0	4	_aDatabases, Factual
650	0	4	_aDiabetes Mellitus, Type 2 _xblood
650	0	4	_aDrug Prescriptions
650	0	4	_aFemale
650	0	4	_aGermany _xepidemiology
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xadverse effects
650	0	4	_aInsulin Detemir _xtherapeutic use
650	0	4	_aInsulin Glargine _xtherapeutic use
650	0	4	_aInsulin, Isophane _xtherapeutic use
650	0	4	_aInsulin, Long-Acting _xadverse effects
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMale
650	0	4	_aMedication Adherence
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aPoland _xepidemiology
650	0	4	_aPolypharmacy
650	0	4	_aProportional Hazards Models
650	0	4	_aRisk Factors
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aCzech, Marcin
700	1		_aFranek, Edward
700	1		_aKostev, Karel
773	0		_tInternational journal of clinical pharmacology and therapeutics _gvol. 55 _gno. 2 _gp. 119-125
856	4	0	_uhttps://doi.org/10.5414/CP202772 _zAvailable from publisher's website
999			_c26633498 _d26633498